- Home
- RAPT vs POET Comparison
RAPT vs POET Comparison
Compare RAPT & POET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RAPT
- POET
- Stock Information
- Founded
- RAPT 2015
- POET 1972
- Country
- RAPT United States
- POET Canada
- Employees
- RAPT N/A
- POET N/A
- Industry
- RAPT Biotechnology: Pharmaceutical Preparations
- POET Semiconductors
- Sector
- RAPT Health Care
- POET Technology
- Exchange
- RAPT Nasdaq
- POET Nasdaq
- Market Cap
- RAPT 498.4M
- POET 468.1M
- IPO Year
- RAPT 2019
- POET N/A
- Fundamental
- Price
- RAPT $28.83
- POET $4.38
- Analyst Decision
- RAPT Strong Buy
- POET Strong Buy
- Analyst Count
- RAPT 9
- POET 2
- Target Price
- RAPT $57.00
- POET $6.25
- AVG Volume (30 Days)
- RAPT 778.5K
- POET 13.0M
- Earning Date
- RAPT 11-06-2025
- POET 11-13-2025
- Dividend Yield
- RAPT N/A
- POET N/A
- EPS Growth
- RAPT N/A
- POET N/A
- EPS
- RAPT N/A
- POET N/A
- Revenue
- RAPT N/A
- POET $762,695.00
- Revenue This Year
- RAPT N/A
- POET $3,433.93
- Revenue Next Year
- RAPT N/A
- POET $596.72
- P/E Ratio
- RAPT N/A
- POET N/A
- Revenue Growth
- RAPT N/A
- POET 535.87
- 52 Week Low
- RAPT $5.67
- POET $3.09
- 52 Week High
- RAPT $42.39
- POET $9.41
- Technical
- Relative Strength Index (RSI)
- RAPT 53.26
- POET 30.97
- Support Level
- RAPT $27.76
- POET $4.97
- Resistance Level
- RAPT $29.90
- POET $5.74
- Average True Range (ATR)
- RAPT 1.66
- POET 0.52
- MACD
- RAPT -0.46
- POET -0.26
- Stochastic Oscillator
- RAPT 41.72
- POET 5.72
About RAPT RAPT Therapeutics Inc.
RAPT Therapeutics Inc is a clinical-stage immunology-based biopharmaceutical company. It is focused on discovering, developing, and commercializing oral small-molecule therapies for patients with some unmet needs in oncology and inflammatory diseases. The company pipeline products include FLX475, designed to selectively inhibit the migration of immunosuppressive regulatory T cells into tumors; and RPT193, designed to selectively inhibit the migration of type 2 T helper cells into inflamed tissues.
About POET POET Technologies Inc.
POET Technologies Inc is a design and development company offering high-speed optical engines, light source products, and custom optical modules to the artificial intelligence systems market and hyperscale data centers. Its integration solutions are based on the POET Optical Interposer, a novel, patented platform that allows the seamless integration of electronic and photonic devices into a single chip using wafer-level semiconductor manufacturing techniques. POET's Optical Interposer platform also solves device integration challenges across a broad range of communication, computing, and sensing applications. The company operates geographically in the United States, Canada, Singapore and China.